The current financial score of Core Scientific Inc is 8.40. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 164.20M, representing a year-over-year increase of 108.83%, while its net profit experienced a year-over-year increase of 8044.31%.
The current valuation score of Core Scientific Inc is 9.26. Its current P/E ratio is -5.34, which is -742.90% below the recent high of 34.35 and -422.31% above the recent low of -27.90.
The current earnings forecast score of Core Scientific Inc is 8.38. The average price target is 33.96, with a high of 55.00 and a low of 20.00.
The current price momentum score of Core Scientific Inc is 5.26. Currently, the stock price is trading between the resistance level at 19.63 and the support level at 15.98, making it suitable for range-bound swing trading.
The current institutional shareholding score of Core Scientific Inc is 10.00. The latest institutional shareholding proportion is 117.59%, representing a quarter-over-quarter increase of 0.64%. The largest institutional shareholder is James Simons, holding a total of 3.32M shares, representing 0.12% of shares outstanding, with 2051.01% increase in holdings.
The current risk assessment score of Core Scientific Inc is 4.04. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.